Anbalcabtagene Autoleucel in Relapsed/Refractory CNS Lymphoma

Clinical trial NCT07062627 · RECRUITING

Trial details

NCT number: NCT07062627
Sponsor: Hyungwoo Cho
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Primary CNS Lymphoma (PCNSL)Diffuse Large B Cell Lymphoma (DLBCL)

Start date: 2025-11-12
Primary completion: 2026-12-31
Enrollment: 12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.